You are here

AveXis

4 Huge Pharma Deals in 4 Months Is Just the Beginning

Motley Fool

Sat, 04/28/18 - 12:18 pm

Juno Therapeutics

First Patient Dosed in Avexis' Phase 3 Trial of AVXS-101 in Pre-Symptomatic Spinal Muscular Atrophy

CP Wire

Wed, 04/25/18 - 10:29 pm

clinical trials

spinal muscular atrophy

[video]Did Novartis Overpay for AveXis?

Motley Fool

Mon, 04/16/18 - 11:34 pm

3 Biotech Stocks That Soared This Week

Motley Fool

Sat, 04/14/18 - 12:37 pm

Abeona Therapeutics

Spectrum Pharmaceuticals

Why Did Novartis Spend $9 Billion On Gene Therapy? CEO Says: 'A Journey To Focus On Data And Digital'

Forbes

Mon, 04/9/18 - 03:31 pm

Biogen faces increased 'pressure' after AveXis buyout by Novartis

Marketwatch

Mon, 04/9/18 - 09:10 am

Novartis buying AveXis for $8.7 billion to strengthen gene therapy capabilities

Stat

Mon, 04/9/18 - 09:00 am

spinal muscular atrophy

Biogen Unlikely To See Spinraza Rival In 2018 As AveXis Delayed

Investors Business Daily

Fri, 01/5/18 - 05:44 pm

spinal muscular atrophy

AveXis gets FDA nod for pivotal gene therapy trial

Biopharma Dive

Mon, 10/2/17 - 11:05 am

The sector’s most valuable unpartnered assets – up for grabs or on the shelf?

EP Vantage

Tue, 08/22/17 - 09:55 am

Portola Pharmaceuticals

DBV Technologies

Biotech's Top 3 Stock Losers, and Winners, in 2016

Forbes

Mon, 01/2/17 - 12:03 pm

Corbus Pharmaceuticals

5 Biotech IPOs Lead The Way In 2016

Seeking Alpha

Mon, 11/28/16 - 09:51 am

Clearside Biomedical

Protagonist Therapeutics

Reata Pharmaceuticals

Biotech's Top 5 Stock Winners, And Losers, In Q1 2016

Forbes

Thu, 03/31/16 - 09:49 pm

PTC Therapeutics

Celldex Therapeutics

Puma Biotechnology

Portola Pharmaceuticals

BioTie Therapies

Editas Medicine

Pages